ACCC signs off on pharma–doctor transparency regime

Doctors receiving payments from big pharma for speaking at educational events or sitting on advisory panels will be named under new rules endorsed by the ACCC last week.

The consumer watchdog finally gave the thumbs up to the Medicines Australia draft code, which governs the actions of the country’s biggest drug companies.

Any “transfer of value” between a company